BLOOMFIELD HILLS, Mich.–( BUSINESS WIRE )–Zivo Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algae cultures, today announced its participation in The Microcap 2025 conference, which will be held January 28-30, 2025 in Atlantic City, NJ
Management will make a corporate presentation and engage in one-on-one meetings with institutional and individual investors to discuss the company’s recent developments, growth strategy and investment opportunities.
Event: Microcap 2025 Conference
Place: Studio 1, Borgata Hotel casino (EPA:) & Spa
Date: Thursday, January 30, 2025
Time: 2:30 PM ET
Investors interested in meeting with management can register for the conference here.
About ZIVO Bioscience
Zivo Bioscience, Inc. is a research and development company with an intellectual property portfolio consisting of proprietary algal and bacterial strains, biologically active molecules and complexes, manufacturing techniques, breeding techniques and patented or patented inventions for human and animal health applications. Please visit www.zivobioscience.com for more information.
See the original version on businesswire.com: https://www.businesswire.com/news/home/20250122415215/en/
LIVE Bioscience
Keith Marchiando, Chief Financial Officer
(248) 452-9866 x130
kmarchiando@zivobioscience.com
Councilors of the Association IR
Tirth T. Patel
(212) 201-6614
tpatel@allianceadvisors.com
Source: Zivo Bioscience, Inc.
